期刊文献+

不同超滤功能的持续不卧床腹膜透析患者腹膜液体转运功能评估 被引量:1

Ultrafiltration capacity and peritoneal fluid kinetics in continuous ambulatory peritoneal dialysis patients
下载PDF
导出
摘要 目的容量控制对于腹膜透析至关重要。腹膜平衡实验(peritoneal equilibration test,PET)可以评估腹膜小分子溶质转动功能,对优化腹膜透析存腹时间提供依据,但是不能预测腹膜液体转运功能。所以,本研究使用计算机拟合对不同超滤功能腹膜透析患者的腹膜液体转运功能进行评估。方法纳入研究患者包括每天使用3~4袋2.5%葡萄糖透析液者(为腹膜超滤功能差组)和使用3~4袋1.5%葡萄糖透析液者(为腹膜功能好组),两组患者在上述透析处方下都能达到足够的液体清除。所有入组的患者都要求详细记录自己每天的腹膜透析换液情况,以评估腹膜液体转运功能。结果本研究包括了17名持续不卧床腹膜透析患者(continuous ambulatory peritoneal dialysis,CAPD),其中9名为超滤功能差组,8名为超滤功能好组。与超滤功能好组相比,超滤功能差组的患者每天更多的处于高葡萄糖(P<0.01)环境中,透析液/血浆肌酐比值(D/Pcre)更高(P<0.05),有更高的腹膜液体吸收率(Ke)(P<0.01)。结论与超滤功能好的患者相比超滤功能差的患者的腹膜小分子溶质转运率更高,更为重要的是,超滤能力差的患者腹膜液体吸收率更高。 Objective Volume control is critical for peritoneal dialysis. Although peritoneal equilibration test (PET) has been used to clarify the peritoneal membrane characteristics, it is unable to adequately predict peritoneal fluid removal and appropriately optimize the dwelling time. In the present study, we applied computer simulation and performed a more detailed evaluation of the fluid kinetics in patients with different ultrafiltration (UF) capacity. Methods Patients who used three to four exchanges of 2.5% glucose dialysate per day (poor UF capacity group) and patients who used three to four exchanges of 1.5% glucose dialysate per day (good UF capacity group) to achieve adequate amount of peritoneal fluid removal were included in the present analysis. All included patients were asked to record appropriately their dialysis exchanges for assessment of their peritoneal fluid transport characteristics. Results Seventeen continuous ambulatory peritoneal dialysis patients were selected in the present study, nine in poor UF capacity group and eight in good UF capacity group. Patients in poor UF capacity group had significantly higher daily glucose exposure (P<0.01), higher dialysate-to-plasma ratio of creatinine (D/P creatinine) (P<0.05) values, and higher peritoneal fluid absorption rate (Ke) (P<0.01), as compared to patients with good UF capacity. Conclusions Our results suggest that patients with poor UF capacity have significantly higher peritoneal small solute transport rate, and more importantly, higher peritoneal fluid absorption rate as compared to patients with good UF capacity.
出处 《中国血液净化》 2012年第5期241-244,共4页 Chinese Journal of Blood Purification
基金 教育部长江学者奖励计划 教育部教育振兴行动计划专项基金(985工程) 北京大学国家211计划(38-18)的资助 云南省科技厅社会发展计划面上项目(2008ZC127M) 昆明市科技局科技计划项目重点项目(昆科计字08S090104) 院内博士启动金(2007bs08)的资助
关键词 腹膜透析 流体力学 超滤容积 Peritoneal dialysis Fluid kinetics Ultrafiltration capacity
  • 相关文献

参考文献1

二级参考文献4

  • 1Wang T,Kidney Int,1999年,55卷,5期,2040页
  • 2Wang T,J Am Soc Nephrol,1997年,8卷,12期,1915页
  • 3Wang C,Am J Pathol,1996年,148卷,6期,1721页
  • 4Yung S,Kidney Int,1994年,46卷,2期,527页

共引文献3

同被引文献15

  • 1俞雨生,张炯,王金泉,胡伟新,唐政,黎磊石.残余肾功能状态对腹膜透析效能的影响[J].肾脏病与透析肾移植杂志,2006,15(6):520-524. 被引量:26
  • 2Argentino G, Russo R, Maresca ID,et al. Imaging of the peritoneum evalu-ated by 99mTc-Ieodextrin seintigraphy in peritoneal dialysis patients:pre- liminary data [J]. Blood Pufif,2014;38(3-4) :219-23.
  • 3Krediet RT, Boeschoten EW, Zuyderhoudt FM,et al. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal di- alysis patients [ J ]. Blood Purif, 1986 ;4 (4) : 194-203.
  • 4Tzeng HE,Tsai CH, Chang ZL, et al. Interleukin-6 induces vascular en- dothelial growth factor expression and promotes angiogenesis through ap- optosis signal-regulating kinase 1 in human osteosarcoma [ J]. Biochem Pharmacol,2013 ;85 (4) :531-40.
  • 5Pawlaczyk K, Polubinska A, Numata N, et al. Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation [ J ]. Int J Artif Organs,2008 ;31 (6) :535-44.
  • 6Prrez Fontan M, Rodriguez-Carmona A, Gareia-Naveiro R, et al. Perito- nitis-related mortality in patients undergoing chronic peritoneal dialysis [ J ]. Petit Dial Int,2005 ;25 ( 3 ) :274-84.
  • 7Hamasaki Y, Doi K,Tanaka M, et al. Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution[J]. BMC Nephrol, 2014 ; 15 : 173.
  • 8戴慧莉,林爱武,钱家麒,方炜,倪兆慧,曹励欧,林星辉,吴青伟.艾考糊精腹膜透析液改善持续非卧床腹膜透析患者的新生血管化[J].中华医学杂志,2010,90(40):2843-2847. 被引量:4
  • 9杭瑛,方炜,林爱武,戴慧莉,倪兆慧,钱家麒.透出液中白介素6和血管生成素受体Tie-2水平与腹膜溶质高转运的关系[J].上海交通大学学报(医学版),2012,32(6):751-755. 被引量:6
  • 10倪兆慧,陈雅.腹膜透析相关腹膜炎发生相关因素及处理对策[J].中国实用内科杂志,2013,33(6):423-426. 被引量:9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部